NCT01430819View on ClinicalTrials.gov

Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza Virus Vaccine: Fluzone® 2011-2012 Formulation

0.5 mL, Intramuscular

BIOLOGICAL

Influenza Virus Vaccine: Fluzone® High-Dose 2011-2012 Formulation

0.5 mL, Intramuscular

Trial Locations (6)

19020

Bensalem

51503

Council Buffs

65804

Springfield

70006

Metairie

78705

Austin

80920

Colorado Springs

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01430819 - Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults | Biotech Hunter | Biotech Hunter